Thursday, February 25, 2016 4:06:55 AM
Genfit is number one in the Nash, the publication in Gastroenterology demonstrates the efficiency of Genfit against Nash.
ICPT has NOT yet started the recruitment of patient for Phase 3, during Conference call, CEO was not able to give a date, and so, ICPT has received the green light for Phase 3 a long time before Genfit ... While for Genfit is totally different .
If I were you, I will buy Genfit while the price is still so low.
Most of Analyst decrease the conscensus of ICPT, when the US Analyst will enforce their projection on Genfit, the price will rise rapidly ...
Fundamentals are strong with Genfit, no doubt on that, publication is there, with all experts of Nash ...
Even Adam Feuerstein, big, defender of ICPT cannot attack Genfit anymore ...
Things are changing ... take the good train ...
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM